The USG seeks information from stakeholders on available medical countermeasures in development. BARDA is particularly interested in products, technologies, and capabilities that have progressed into or beyond clinical trials, have established large-scale cGMP manufacturing capability, or utilize an approved platform.
These requests are for market research purposes only and are not considered submissions for potential funding.
You’re offline. This is a read only version of the page.
